How Are Cancer Treatments Monitored Post-Approval?
Even after a drug is approved, regulatory agencies continue to monitor its safety and effectiveness through post-marketing surveillance. This involves collecting and analyzing data from patients using the drug in real-world settings. Any adverse effects or new findings are reported, and if necessary, regulatory actions, such as updating labels or restricting use, are taken.
